Apolipoproteins E < Apomorphine < Apoptosis

Facettes :

List of bibliographic references indexed by Apomorphine

Number of relevant bibliographic references: 25.
[0-20] [0 - 20][0 - 25][20-24][20-40]

Ident.	Authors (with country if any)	Title
000429 (2016)	Serdar Durdagi [Turquie] ; Ramin Ekhteiari Salmas [Turquie] ; Matthias Stein [Allemagne] ; Mine Yurtsever [Turquie] ; Philip Seeman	Binding Interactions of Dopamine and Apomorphine in D2High and D2Low States of Human Dopamine D2 Receptor Using Computational and Experimental Techniques.
001D42 (2010)	M. Lafreniere-Roula [Canada] ; O. Darbin [États-Unis] ; W. D. Hutchison [Canada] ; T. Wichmann [États-Unis] ; A. M. Lozano [Canada] ; J. O. Dostrovsky [Canada]	Apomorphine reduces subthalamic neuronal entropy in parkinsonian patients
001E56 (2009)	Atsuko Nagano-Saito [Canada] ; Jiaqiang Liu ; Julien Doyon ; Alain Dagher	Dopamine modulates default mode network deactivation in elderly individuals during the Tower of London task.
002491 (2007)	Elena I. Miklyaeva [Canada] ; Ian Q. Whishaw ; Bryan Kolb	A golgi analysis of cortical pyramidal cells in the unilateral parkinson rat: absence of change in the affected hemisphere vs hypertrophy in the intact hemisphere.
002904 (2006)	Evelyn F. Field [Canada] ; Gerlinde A. Metz [Canada] ; Sergio M. Pellis [Canada] ; Ian Q. Whishaw [Canada]	Sexually dimorphic postural adjustments during vertical behaviour are altered in a unilateral 6-OHDA rat model of Parkinson's disease
002915 (2006)	Rohita Sharma [Canada] ; Catherine R. Mcmillan [Canada] ; Catherine C. Tenn [Canada] ; Lennard P. Niles [Canada]	Physiological neuroprotection by melatonin in a 6-hydroxydopamine model of Parkinson's disease
002928 (2006)	G. Rasouli [Canada] ; M. Rasouli [Canada] ; F. A. Lenz [États-Unis] ; L. Verhagen [États-Unis] ; D. S. Borrett [Canada] ; H. C. Kwan [Canada]	Fractal characteristics of human parkinsonian neuronal spike trains
002952 (2005)	Kelly K. Meissner [Canada] ; David L. Kirkham ; Laurie C. Doering	Transplants of neurosphere cell suspensions from aged mice are functional in the mouse model of Parkinson's.
002961 (2005)	William J. Weiner [États-Unis]	Research update on Parkinson's disease and other movement disorders: highlights from the Eighteenth Annual Symposium on the Etiology, Pathogenesis, and Treatment of Parkinson's Disease and Other Movement Disorders, October 3, 2004, Toronto, Ontario, Canada.
002A20 (2005)	Gerlinde A. Metz [Canada] ; Arthur Tse ; Mark Ballermann [Canada] ; Lori K. Smith [Canada] ; Karim Fouad [Canada]	The unilateral 6‐OHDA rat model of Parkinson's disease revisited: an electromyographic and behavioural analysis
002D09 (2004)	Gerlinde A. Metz [Canada] ; Dionne M. Piecharka [Canada] ; Jeffrey A. Kleim [Canada] ; Ian Q. Whishaw [Canada]	Preserved ipsilateral-to-lesion motor map organization in the unilateral 6-OHDA-treated rat model of Parkinson's disease
002E00 (2003)	Patricia Vergara-Aragon ; Claudia L R. Gonzalez ; Ian Q. Whishaw	A novel skilled-reaching impairment in paw supination on the "good" side of the hemi-Parkinson rat improved with rehabilitation.
003091 (2002)	Raul De La Fuente-Fernandez [Canada] ; Anthony G. Phillips [Canada] ; Mariangela Zamburlini [Canada] ; Vesna Sossi [Canada] ; Donald B. Calne [Canada] ; Thomas J. Ruth [Canada] ; A. Jon Stoessl [Canada]	Dopamine release in human ventral striatum and expectation of reward
003117 (2001)	R. Levy [Canada] ; J O Dostrovsky ; A E Lang ; E. Sime ; W D Hutchison ; A M Lozano	Effects of apomorphine on subthalamic nucleus and globus pallidus internus neurons in patients with Parkinson's disease.
003326 (2001)	Raul De La Fuente-Fernandez [Canada] ; Thomas J. Ruth [Canada] ; Vesna Sossi [Canada] ; Michael Schulzer [Canada] ; Donald B. Calne [Canada] ; A. Jon Stoessl [Canada]	Expectation and dopamine release: Mechanism of the placebo effect in Parkinson's disease
003353 (2001)	Raul De La Fuente-Fernandez [Canada] ; Andrew S. Lim [Canada] ; Vesna Sossi [Canada] ; James E. Holden [États-Unis] ; Donald B. Calne [Canada] ; Thomas J. Ruth [Canada] ; A. Jon Stoessl [Canada]	Apomorphine-induced changes in synaptic dopamine levels : Positron emission tomography evidence for presynaptic inhibition
003513 (2000)	J. M. Van Kampen [Canada] ; E. G. Mcgeer [Canada] ; A. Jon Stoessl [Canada]	Dopamine transporter function assessed by antisense knockdown in the rat: Protection from dopamine neurotoxicity
003575 (2000)	A. M. Lozano [Canada] ; A. E. Lang [Canada] ; R. Levy [Canada] ; W. Hutchison [Canada] ; J. Dostrovsky [Canada]	Neuronal recordings in Parkinson's disease patients with dyskinesias induced by apomorphine
003628 (1999)	T L Sourkes [Canada]	"Rational hope" in the early treatment of Parkinson's disease.
003B92 (1997)	Simon Hutchison [Canada] ; R. Levy [Canada] ; J. O. Dostrovsky [Canada] ; A. M. Lozano [Canada] ; A. E. Lang [Canada]	Effects of apomorphine on globus pallidus neurons in parkinsonian patients
003C75 (1997)	D. D. Newman [Canada] ; N. Rajakumar ; B. A. Flumerfelt ; A. J. Stoessl [Canada]	A kappa opioid antagonist blocks sensitization in a rodent model of Parkinson's disease

---

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Wicri/Canada/explor/ParkinsonCanadaV1/Data/Main/Exploration

HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/Mesh.i -k "Apomorphine" 

HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/Mesh.i  \
                -Sk "Apomorphine" \
         | HfdSelect -Kh $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd 

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Wicri/Canada
   |area=    ParkinsonCanadaV1
   |flux=    Main
   |étape=   Exploration
   |type=    indexItem
   |index=    Mesh.i
   |clé=    Apomorphine
}}

---

This area was generated with Dilib version V0.6.29. Data generation: Thu May 4 22:20:19 2017. Site generation: Fri Dec 23 23:17:26 2022